INTEGRA LIFESCIENCES HOLDINGS CORP
NASDAQ: IART. Canonical company identity and public leadership record.
US
- Alpha ID
- alpha:company:2a76f1e7-b420-475e-a9b1-6a755c0ccbbe
- SEC CIK
- 0000917520
- Record version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 16, 2026
- Newest evidence
- May 3, 2026
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- CEO
- Jan De WittePresident and Chief Executive Officer
- Chair
- Stuart M. Essig
- Independent
- Not published6 directors published
- Published claims
- 233 distinct sources
- Evidence records
- 60 pinned
- Source conflicts
- 0None open
Built from 3 distinct sources and 6 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works
CFO CHANGED
Lester B. Knight executive of INTEGRA LIFESCIENCES HOLDINGS CORP, effective 2026-04-06.
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- Evidencesource_reportedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Leadership
Evidence| Role | Person | Since | Status | Claim |
|---|---|---|---|---|
| Executive Vice President and Chief Financial Officer | Lester B. Knight | Apr 2026 | current | Source reportedE6 |
| Executive Vice President and Chief Human Resources Officer | Chantal Veillon | Not captured | unknown | Source reportedE2 |
| Executive Vice President, Chief Legal Officer and Secretary | Eric I. Schwartz | Not captured | unknown | Source reportedE4 |
| Executive Vice President and President, International | Harvinder Singh | Not captured | unknown | Source reportedE2 |
| President and Chief Executive Officer | Jan De Witte | Not captured | unknown | Source reportedE5 |
| Senior Vice President, Finance and Principal Accounting Officer | Jeffrey Mosebrook | Not captured | unknown | Source reportedE2 |
| Executive Vice President and Chief Financial Officer | Lea Knight | Not captured | unknown | Source reportedE2 |
| Executive Vice President, Chief Legal Officer and Secretary | Michael Hutchinson | Not captured | unknown | Source reportedE2 |
| Executive Vice President, President, Codman Specialty Surgical | Michael McBreen | Not captured | unknown | Source reportedE2 |
| President and Chief Executive Officer | Mojdeh Poul | Not captured | unknown | Source reportedE2 |
| Executive Vice President, President, Tissue Technologies | Robert T. Davis, Jr. | Not captured | unknown | Source reportedE2 |
Board of directors
Evidence6 directors published. Independence determinations are not published for every director.
| Director | Status | Since | Committees | Claim |
|---|---|---|---|---|
| Barbara B. Hill | Independence not published | 2013 | None published | Source reportedE3 |
| Christian S. Schade | Independence not published | 2006 | None published | Source reportedE3 |
| Jeffrey A. Graves | Independence not published | 2023 | None published | Source reportedE3 |
| Keith Bradley | Independence not published | 1992 | None published | Source reportedE3 |
| Renee W. Lo | Independence not published | 2022 | None published | Source reportedE3 |
| Shaundra D. Clay | Independence not published | 2021 | None published | Source reportedE3 |
| Mojdeh Poul | Not independent | Not published | None published | Source reportedE2 |
| Stuart M. Essig | Not independentChair | Not published | None published | Source reportedE2 |
Committees and risk ownership
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Control and voting power
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Authority to act
Evidence and agent registryWho can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.
Financials and market context
EvidenceGovernance and policies
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Risk, audit, and cyber
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
AI oversight and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Legal and regulatory
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Compensation
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- CommitteesNot reviewed. Committee mandates show where oversight is delegated.
- OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
- FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
- CompensationNot reviewed. Pay design shows how incentives are governed.
- GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
- AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
- LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
- RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
- CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
- Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.
Linked people
Same claims as person records- Lester B. KnightExecutive Vice President and Chief Financial Officercompany:2a76f1e7-b420-475e-a9b1-6a755c0ccbbe:leadership_role:19
- Chantal VeillonExecutive Vice President and Chief Human Resources Officercompany:2a76f1e7-b420-475e-a9b1-6a755c0ccbbe:leadership_role:13
- Eric I. SchwartzExecutive Vice President, Chief Legal Officer and Secretarycompany:2a76f1e7-b420-475e-a9b1-6a755c0ccbbe:leadership_role:14
- Harvinder SinghExecutive Vice President and President, Internationalcompany:2a76f1e7-b420-475e-a9b1-6a755c0ccbbe:leadership_role:15
- Jan De WittePresident and Chief Executive Officercompany:2a76f1e7-b420-475e-a9b1-6a755c0ccbbe:leadership_role:16
- Jeffrey MosebrookSenior Vice President, Finance and Principal Accounting Officercompany:2a76f1e7-b420-475e-a9b1-6a755c0ccbbe:leadership_role:17
- Lea KnightExecutive Vice President and Chief Financial Officercompany:2a76f1e7-b420-475e-a9b1-6a755c0ccbbe:leadership_role:18
- Michael HutchinsonExecutive Vice President, Chief Legal Officer and Secretarycompany:2a76f1e7-b420-475e-a9b1-6a755c0ccbbe:leadership_role:20
- Michael McBreenExecutive Vice President, President, Codman Specialty Surgicalcompany:2a76f1e7-b420-475e-a9b1-6a755c0ccbbe:leadership_role:21
- Mojdeh PoulPresident and Chief Executive Officer; President and Chief Executive Officer and Directorcompany:2a76f1e7-b420-475e-a9b1-6a755c0ccbbe:leadership_role:22, company:2a76f1e7-b420-475e-a9b1-6a755c0ccbbe:leadership_role:10
- Robert T. Davis, Jr.Executive Vice President, President, Tissue Technologiescompany:2a76f1e7-b420-475e-a9b1-6a755c0ccbbe:leadership_role:23
- Barbara B. HillDirectorcompany:2a76f1e7-b420-475e-a9b1-6a755c0ccbbe:leadership_role:6
- Christian S. SchadeDirectorcompany:2a76f1e7-b420-475e-a9b1-6a755c0ccbbe:leadership_role:7
- Jeffrey A. GravesDirectorcompany:2a76f1e7-b420-475e-a9b1-6a755c0ccbbe:leadership_role:8
- Keith BradleyDirectorcompany:2a76f1e7-b420-475e-a9b1-6a755c0ccbbe:leadership_role:9
- Renee W. LoDirectorcompany:2a76f1e7-b420-475e-a9b1-6a755c0ccbbe:leadership_role:11
- Shaundra D. ClayDirectorcompany:2a76f1e7-b420-475e-a9b1-6a755c0ccbbe:leadership_role:12
- Stuart M. EssigNon-Executive Chairman of the Boardcompany:2a76f1e7-b420-475e-a9b1-6a755c0ccbbe:leadership_role:5
Subject and corrections
Public-role doctrineThis record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.
- Basis
- Published company record built from public sources
- Sources
- 6 evidence records cited. 0 with redistribution rights.
- Never published
- Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
- Record claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.
Evidence
Authority and rights- E1Alpha canonical company public projection. canonical identity. Retrieved Oct 16, 2026. Cited by 4 Claims.
- E2sec def 14a. Published Apr 6, 2026. Retrieved Sep 6, 2026. Cited by 10 Claims.
- E3sec proxy. Published Apr 6, 2026. Retrieved Sep 2, 2026. Cited by 6 Claims.
- E4IART executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E5IART executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E6sec filing. Published Apr 6, 2026. Retrieved May 15, 2026. Cited by 1 Claim.
What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 16, 2026- Lester B. Knight executive of INTEGRA LIFESCIENCES HOLDINGS CORP, effective 2026-04-06.
- Jeffrey A. Graves seat on INTEGRA LIFESCIENCES HOLDINGS CORP, effective 2023-01-01.
- Renee W. Lo seat on INTEGRA LIFESCIENCES HOLDINGS CORP, effective 2022-01-01.
- Shaundra D. Clay seat on INTEGRA LIFESCIENCES HOLDINGS CORP, effective 2021-01-01.
- Barbara B. Hill seat on INTEGRA LIFESCIENCES HOLDINGS CORP, effective 2013-01-01.
- Christian S. Schade seat on INTEGRA LIFESCIENCES HOLDINGS CORP, effective 2006-01-01.
- Keith Bradley seat on INTEGRA LIFESCIENCES HOLDINGS CORP, effective 1992-01-01.



